2021
DOI: 10.1126/sciadv.abe0143
|View full text |Cite
|
Sign up to set email alerts
|

Deformable microparticles for shuttling nanoparticles to the vascular wall

Abstract: Vascular-targeted drug carriers must localize to the wall (i.e., marginate) and adhere to a diseased endothelium to achieve clinical utility. The particle size has been reported as a critical physical property prescribing particle margination in vitro and in vivo blood flows. Different transport process steps yield conflicting requirements—microparticles are optimal for margination, but nanoparticles are better for intracellular or tissue delivery. Here, we evaluate deformable hydrogel microparticles as carrie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
23
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(25 citation statements)
references
References 55 publications
0
23
0
Order By: Relevance
“…By entrapping various stimuli-responsive compartments, minimal cross-reactivity and control over the release sequence could be embedded within a single synthetic eukaryote. The assembly of such an endomembrane system within a micron-scale carrier could be engineered to release therapeutics through the vascular walls, 59 while enabling improved functionality, reduced passive leakage, cross-reactivity, and flexibility to name a few.…”
Section: Discussionmentioning
confidence: 99%
“…By entrapping various stimuli-responsive compartments, minimal cross-reactivity and control over the release sequence could be embedded within a single synthetic eukaryote. The assembly of such an endomembrane system within a micron-scale carrier could be engineered to release therapeutics through the vascular walls, 59 while enabling improved functionality, reduced passive leakage, cross-reactivity, and flexibility to name a few.…”
Section: Discussionmentioning
confidence: 99%
“…However, while the particles we have used in this study are not intended for use in a clinical setting, there are several ways to implement such micron or sub-micron sized carriers while minimizing the potential limitations and the filtering effects of relatively large carriers. One of the ways is the use of deformable carriers that mimic the physics of the red blood cells, which has been shown to increase circulation time and reduce accumulation of carriers within the lung and liver as well as reduce patient toxicity 42,43 .…”
Section: Discussionmentioning
confidence: 99%
“…One of the ways is the use of deformable carriers that mimic the physics of the red blood cells, which has been shown to increase circulation time and reduce accumulation of carriers within the lung and liver as well as reduce patient toxicity. 42 , 43 Additionally, RBC‐based drug carriers have recently shown a remarkable improvement in targeting lung and other organs. 44 Furthermore, such RBC carriers can be made to adhere to exposed collagen, 45 are about 10 μm in diameter and have relatively long circulation time, and thus could potentially be valuable for targeting high‐risk brain aneurysms.…”
Section: Discussionmentioning
confidence: 99%
“…They presented that there is an optimal stiffness value for the particles with high margination probabilities based on the adhesion strength 81 . Fish et al 82 also employed nanoparticle‐loaded PEGDA microparticles in a blood vessel model for the optimization of microparticle modulus for efficient margination and nanoparticle delivery.…”
Section: Application Of Mechanically Tailored Soft Microparticlesmentioning
confidence: 99%